BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, January 7, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 14, 2021
View Archived Issues
Patient recruitment ongoing in two phase I/II trials of TQ-05105 in GvHD
Read More
Enrollment ongoing in phase II study of ISA-101b vaccine plus cemiplimab in HPV16 cervical cancer
Read More
Tyrosine-protein kinase ITK/TSK inhibitors discovered at Pfizer
Read More
Roche, Monash University describe IL-37 fusion proteins
Read More
Genfit presents prodrugs of nuclear receptor ROR-gamma modulators
Read More
Janssen Pharmaceutica discovers menin/MLL interaction inhibitors
Read More
ERK-1/2 inhibitor GIZH298 demonstrates antiseizure effects in vivo
Read More
VRG-101: a new PIKfyve inhibitor for SARS-CoV-2
Read More
AR-712 MAb cocktail neutralizes SARS-CoV-2 Delta variant
Read More
Ionis and Bicycle Therapeutics enter licensing agreement to advance LICA technology
Read More
miR-491-5p and miR-592 are downregulated in overactive bladder
Read More
PAT-DX3 shows the ability to cross blood-brain barrier in models of GBM
Read More
Hepion reports phase IIa topline data on CRV-431 in presumed F2 and F3 NASH
Read More
Genocea initiates phase I/IIa study of neoantigen-targeted T cell therapy GEN-011
Read More
XVR-011 shows neutralization activity against the Gamma and Delta variants of SARS-CoV-2
Read More
ACE2 and TLR7 are highly expressed in severe patients with COVID-19
Read More
SFX-01 shown to be effective in in vitro models of blood cancers
Read More
First cohort of subjects dosed in ASC-42 bridging study in China
Read More
FDA clears IND for Kintor's GT-20029 for androgenetic alopecia and acne
Read More
Barcoding strategy tracks breast cancer metastases
Read More
ENA studies INNA-051 nasal spray in phase I to boost innate immunity against respiratory viruses
Read More
TP-03 enhances the stimulating effect of hCG on testicular steroidogenesis
Read More
Oryzon cleared to begin phase IIb trial of vafidemstat in schizophrenia
Read More
Valo submits CTA for first-in-human study of PeptiCRAd-1 in melanoma, TNBC and NSCLC
Read More
Oral fadraciclib enters phase I/II study in advanced solid tumors
Read More
